Celldex therapeutics, inc. (CLDX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash Flows From Operating Activities:
Net Loss

-12,625

-10,447

-11,413

-11,779

-17,239

-9,403

-7,243

-16,406

-118,132

-3,841

-26,363

-28,566

-34,261

-32,307

-29,598

-31,952

-34,673

-32,684

-31,980

-32,359

-30,174

-31,822

-28,081

-28,274

-29,903

-22,062

-23,140

-19,016

-17,332

-16,807

-15,027

-13,773

-13,516

-12,732

-11,772

-10,236

-10,059

Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation and Amortization

1,165

-

-

-

1,352

-

-

-

1,028

1,022

1,025

1,001

1,366

960

701

692

742

847

767

712

672

624

603

582

579

510

479

475

468

471

503

529

544

552

566

568

562

Amortization of Intangible Assets

-

-

-

-

-

0

0

0

224

224

224

224

224

237

253

254

253

253

253

254

253

253

253

254

253

253

253

254

253

254

253

292

291

291

656

483

483

Amortization and Premium of Marketable Securities, Net

63

160

328

307

345

382

286

225

155

119

10

138

23

-158

-156

-83

-529

-851

-727

9

1,219

-849

-682

-693

2,129

134

-717

980

969

240

263

-216

373

-113

-146

486

-244

Realized Gain on Sales and Maturities of Marketable Securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12

0

2

4

0

3

-3

-5

Loss on Sale or Disposal of Assets

-

-4

0

18

-25

-50

-101

-1,059

-10

-

-

-

-

-7

0

-4

-70

-

-

-

-

-

-

-

-

-

-

-

-

0

62

35

-23

0

3

0

55

Goodwill Impairment

-

-

-

-

-

0

0

0

90,976

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible Asset Impairment

-

-

-

-

-

-

-

-

18,677

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Asset Impairment

-

0

0

0

1,800

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on Fair Value Remeasurement of Contingent Consideration

-234

-318

2,114

1,017

-1,519

1,653

6,935

7,433

13,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on Fair Value Remeasurement of Contingent Consideration

-

-

-

-

-

-

-

-

-

-

-4,600

1,000

3,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-Cash Income Tax Benefit

-

-

-

-

-

0

0

0

-765

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-Based Compensation Expense

687

687

707

1,464

1,693

1,752

1,793

2,048

2,488

2,584

2,739

3,450

3,539

3,608

3,796

3,973

3,940

4,097

3,869

2,527

2,281

2,133

1,958

1,511

1,250

1,148

2,016

676

708

684

526

447

641

639

570

553

580

Non-Cash Expense

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,638

72

72

72

72

-

-

-

-

0

0

41

56

57

58

54

57

57

58

57

135

Changes in Operating Assets and Liabilities:
Accounts and Other Receivables

93

161

-443

-1,137

-855

-13

77

-922

1,635

-1,133

1,654

-25

-400

205

463

269

-123

443

93

-245

252

-2,478

2,380

220

-184

-401

878

-92

60

12

-29

-79

-30

-34

41

-80

-81

Prepaid and Other Current Assets

-206

-154

-345

436

-299

-238

-744

-945

144

-268

-1,036

-478

989

-1,645

-2,799

1,383

1,741

175

-1,359

1,799

38

598

-397

774

1,051

-751

1,033

-810

1,234

-41

-485

-179

672

-183

-466

246

162

Other Assets

-

-

-

-

-

-

-

-

-

-73

67

0

-199

-

-

-

-

0

-104

-68

166

-16

-17

-16

-16

-9

-17

-62

-188

15

-19

-32

131

-19

-19

-33

37

Accounts Payable and Accrued Expenses

-853

563

714

-143

-1,455

-3,864

-3,351

24

-5,919

2,144

-4,076

1,503

-8,315

6,590

-1,348

-5,255

-4,957

4,945

-2,594

5,744

-3,220

2,190

293

636

-1,669

4,282

2,845

-97

206

2,267

2,488

56

-1,049

1,520

1,493

-8

-929

Other Liabilities

-768

-3,064

-702

-1,096

-1,737

-2,902

31

678

-1,075

-3,376

-421

236

-802

-953

-251

23

-826

8,492

-275

-217

-798

1,585

-323

4,720

595

-115

1,270

-354

516

-26

47

-33

606

-46

-214

-166

288

Net Cash Used in Operating Activities

-12,110

-11,000

-11,140

-11,042

-13,233

-15,430

-14,388

-17,395

-28,022

-19,521

-24,361

-20,787

-35,262

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-34,902

-

-27,791

-24,762

-32,589

-22,214

-26,592

-20,856

-31,875

-14,957

-17,454

-18,058

-17,200

-13,326

-10,944

-11,959

-13,553

-9,370

-8,059

-9,365

-8,864

Cash Flows From Investing Activities:
Sales and Maturities of Marketable Securities

22,200

21,700

24,087

29,500

37,886

23,134

72,153

59,311

46,871

35,553

32,213

77,734

73,736

47,877

45,548

74,428

74,939

31,741

43,004

29,278

57,067

20,017

38,628

19,304

31,283

8,215

10,097

13,188

7,394

6,928

24,513

15,007

5,912

12,650

19,959

9,741

8,653

Purchases of Marketable Securities

-

18,371

18,446

37,161

21,404

19,624

74,656

45,785

31,117

48,745

30,266

41,008

50,961

24,048

29,824

71,193

48,860

12,590

29,381

43,893

120,541

2,155

19,937

13,806

112,416

19,718

3,555

35,036

53,809

11,355

18,517

5,995

33,388

4,500

9,490

35,482

3,245

Acquisition of Property and Equipment

235

105

142

298

186

162

60

332

259

190

282

942

374

638

806

767

540

407

1,361

1,547

1,561

163

672

899

195

2,318

984

755

162

110

71

80

42

106

121

80

202

Proceeds from Sale or Disposal of Assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

62

145

11

0

4

0

64

Net Cash Provided by Investing Activities

21,965

3,224

5,519

-7,959

16,296

3,348

-2,221

13,194

15,495

-13,382

1,665

35,784

22,401

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,539

-

12,262

-16,162

-65,035

17,699

18,019

4,599

-81,328

-13,821

5,558

-22,582

-46,577

-4,537

5,987

9,077

-27,507

8,044

10,352

-25,821

5,270

Cash Flows From Financing Activities:
Net Proceeds from Stock Issuances

1,613

2,422

2,463

7,212

4,151

3,569

5,493

8,271

11,689

18,383

11,153

8,668

12,821

-

-

-

-

0

0

66

188,774

-

-

-

-

181,510

0

0

114,187

20,912

10,915

28

51,929

-

-

-

-

Proceeds from Issuance of Stock from Employee Benefit Plans

24

0

0

0

9

0

45

0

374

73

116

0

76

4

183

69

280

318

736

272

2,985

11

304

154

702

2,472

637

634

1,660

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

1,637

2,422

2,463

7,212

4,160

3,569

5,538

8,271

12,063

18,456

11,269

8,668

12,897

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of Term Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

9,706

1,323

-

-

-

-

-

-

-

-

(Payments) Issuance of Term Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

Payment of Convertible Subordinated Debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

12,503

Payments of Other Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

428

15

14

15

14

12

14

15

14

14

12

46

Net Cash Provided by Financing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

280

-

736

338

191,759

11

304

154

702

183,554

622

-9,086

114,509

19,573

9,580

-1,309

51,914

129

-23

35,877

-7,549

Effect of Exchange Rate Changes on Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

15

-1

-3

-2

1

0

0

-1

-2

0

1

-1

2

-1

-3

-1

-4

Net Decrease in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-464

-14,447

-11,427

23,665

36

10,718

-739

-30,543

-9,083

5,317

-14,793

-40,586

94,150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Decrease in Cash and Cash Equivalents

11,492

-

-3,158

-11,789

7,223

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Increase (Decrease) in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-112,500

-

-11,274

-49,727

50,730

1,710

4,624

-4,192

10,856

-1,198

2,267

690

-11,147

Non-cash Investing Activities
Acquisition of Property and Equipment Included in Accounts Payable and Accrued Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-43

-170

278

-

-465

-336

839

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued construction in progress

462

-

-

-10

65

-

-

-

212

-55

-12

-283

370

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash Supplemental Disclosure
Shares issued to former Kolltan executive for settlement of severance

-

-

-

-

-

6

8

19

38

42

39

54

209

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-